Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01350 (
gastrin
)
9,683
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In conscious rats and in anaesthetized gastric fistula rats, the effects of low and high doses of the histamine H2-receptor antagonist cimetidine was studied on gastric mucosal histamine concentration and
histidine decarboxylase
activity with or without concomitant administration of pentagastrin. In conscious animals a singleinjection of pentagastrin reduced gastric mucosal histamine concentration and elevated
histidine decarboxylase
activity. This effect was not antagonized by low doses of cimetidine. High doses of cimetidine, like pentagastrin, reduced the histamine concentration and elevated the
histidine decarboxylase
activity. In anaesthetized rats low doses of cimetidine and reduced gastric acid secretion. The effects of cimetidine on gastric mucosal histamine and
histidine decarboxylase
were less pronounced than in conscious animals. The
histidine decarboxylase
stimulating activity of high doses of cimetidine was not abolished by gastric perfusion with acid suggesting that endogenously released
gastrin
is not involved. A feedback relationship between the blockade of the target organ and increased histamine biosynthesis is discussed.
...
PMID:Effect of cimetidine on gastric mucosal histamine and histidine decarboxylase activity in rats. 1 45
Nephrectomy caused a marked increase in the concentration of circulating
gastrin
immunoreactivity but did not increase basal acid secretion. In normal rats, both histamine and pentagastrin stimulated gastric acid output, but after nephrectomy only histamine was effective.
Histidine decarboxylase
in the oxyntic mucosa was greatly activated following nephrectomy. Thus, in the nephrectomized rat
gastrin
(and pentagastrin) no longer evoked acid secretion, whereas it retained its ability to activate gastric
histidine decarboxylase
. The results suggest that the kidney is important for metabolism and excretion not only of
gastrin
but of humoral antagonists of
gastrin
-induced acid secretion as well.
...
PMID:Effect of bilateral nephrectomy on serum gastrin concentration, gastric histamine content, histidine decarboxylase activity, and acid secretion in the rat. 5 28
In unoperated fasted rats, feeding raised the serum
gastrin
concentration, reduced the gastric mucosal histamine content and activated the gastric
histidine decarboxylase
. The reduction of gastric histamine and activation of
histidine decarboxylase
was induced also by the injection of pentagastrin. In antrectomized rats, feeding failed to produce these effects. Injection of pentagastrin, however, still lowered gastric histamine and activated gastric
histidine decarboxylase
. Thus, antral
gastrin
seems to be an obligatory mediator of the postprandial activation of
histidine decarboxylase
and mobilization of histamine.
...
PMID:Gastrin: obligatory intermediate in the postprandial mobilization of gastric histamine in the rat. 7 83
Gastric acid secretion, pepsin concentration in gastric juice and acetylcholinesterase and
histidine decarboxylase
activities in gastric mucosa of rats treated with dichlorvos (DDVP) were investigated. The increase of HCl secretion, the decrease of acetylcholinesterase activity and enhanced activity of
histidine decarboxylase
were observed. It is suggested that a higher gastric acid secretion is secondary to histamine production in gastric mucosa, induced by acetylcholine yields
gastrin
yields
histidine decarboxylase
mechanism.
...
PMID:Dichlorvos intoxication and gastric secretion. 11 26
The regulation patterns of gastric acid secretion in rats were investigated. Pentagastrin and histamine stimulate gastric acid secretion, but the inhibitors of DNA-dependent synthesis of RNA and of proteins prevent only the pentagastrin action. It has been found that pentagastrin induces
histidine decarboxylase
in gastric mucosa, ensuring local accumulation of histamine. The latter activates adenylate cyclase and results in 3',5'-AMP accumulation in gastric tissues. The administration of pentagastrin, histamine or 3',5'-AMP enhances the activity of gastric carbonic anhydrase, the enzyme which takes part in HCl formation. The data suggest that these three compounds act sequentially (pentagastrin leads to histamine leads to3',5'-AMP) and the effect of the last one could be mediated through 3',5'-AMP dependent protein kinase. The experiments in vitro demonstrated that gastric carbonic anhydrase can be separated into two isoenzymes and thephosphorylation of one of them by the 3',5'-AMP dependent protein kinase sharply increases its activity. The findings raise the possibility that histamine and 3',5'-AMP, mediating
gastrin
action, form together with enzymes (
histidine decarboxylase
, adenylate cyclase, protein kinase, carbonic anhydrase) a caascade of amplifiers. Autoradiographic studies have shown that [3H]-pentagastrin is not bound by oxyntic cells but adheres preferentially to histamine-producing alpha-like endocrine cells and to the chief cells, while 3H-histamine adheres preferentially to oxyntic and to chief cells. Electron microscopy indicates that only pentagastrin (but not histamine) initiates in alpha-like endocrine cells ultrastructural changes characteristic for induction. Pentagastrin, histamine and 3',5'-AMP administration produces in oxyntic cells ultrastructural changes typical for the secretion processes. These results lead to assumption that pentagastrin (
gastrin
) induces
histidine decarboxylase
in alpha-like endocrine cells of gastric glands. Histamine which is secreted enhances adenylate cyclase activity in the neighbouring oxyntic cells where 3',5'-AMP dependent protein kinase activates carbonic anhydrase by means of phosphorylation. These different cells form, probably, a multicellular functional unit for gastric acid secretion.
...
PMID:Integration of biochemical functions of different cells of rat gastric mucosa for hydrochloric acid secretion. 18 10
1 Treatment with histamine H2-receptor antagonists, which inhibit basal acid secretion was found to activate rat stomach
histidine decarboxylase
. At the same time the serum
gastrin
concentration was greatly increased. 2 In antrectomized rats neither the enzyme activity nor the serum
gastrin
concentration was affected by the treatment. 3 In analogy with previous observations on other inhibitors of acid secretion we suggest that the H2-receptor antagonists stimulate
gastrin
release through their effect on acid secretion and that the raised serum
gastrin
level is responsible for the enzyme activation.
...
PMID:Activation of histidine decarboxylase by H2-receptor blockade: mechanism of action. 23 59
The location and discovery of
histidine decarboxylase
and aromatic L-amino acid decarboxylase in the stomach are described. Feeding and
gastrin
-like agents stimulate increased gastric
histidine decarboxylase
(HD) acttvity in rats. Procedures which result in increased
gastrin
release - often by raising antral pH - also have this action in intact but not in antrectomised rats. Evidence for a histaminic feedback mechanism controlling HD levels is discussed. HD activity is reduced by protein synthesis inhibitors and by chronic pyridoxine deficiency. The effects of inhibitors of HD on gastric secretion in rat, dog and man are reviewed. The role of HD and histamine in gastric secretion is considered.
...
PMID:Amino acid decarboxylase enzymes--vital or irrelevant to gastric secretion? 24 75
Endocrine tumours (argyrophil cell carcinoids) are frequent in the oxyntic mucosa of mastomys. The tumour is notable for its high histamine content and for its high
histidine decarboxylase
activity. The tumour is thought to arise from the histamine-storing, enterochromaffin-like cells of the oxyntic mucosa. They are of two ultrastructurally distinguishable types, ECL cells and A-like cells, both of which have been demonstrated in the tumour. Identical cells have been demonstrated in the oxyntic mucosa of the rat; there is much evidence that in this species the functional activity and the number of these cells are determined by the serum
gastrin
concentration. However, tumours have never been found to arise from these cells in the rat. As an initial step in an attempt to explain the formation of the gastric endocrine tumour in the mastomys we examined the distribution and frequency of occurrence of endocrine cells in the mastomys stomach.
Gastrin
cells in the antrum of mastomys seemed to occur in about the same frequency as in the antrum of rat and mouse. 5-HT-storing enterochromaffin cells, however, were considerably more numerous in the mastomys, whereas the somatostatin cells in the antrum were fewer. The number of enterochromaffin-like cells and somatostratin cells in the oxyntic mucosa of mastomys was much lower than in the rat and mouse. Once developed, the gastric endocrine tumour seems to reduce the antral
gastrin
cell number; the larger the tumour the greater the reduction.
...
PMID:Spontaneous argyrophil cell carcinoid in the glandular stomach: immunohistochemical study of gastric endocrine cells in normal and tumour-bearing mastomys. 38 3
1. Following antrum exclusion the serum
gastrin
concentration was raised and independent of the prandial state. The antral
gastrin
concentration and number of
gastrin
cells were greatly lowered. 2. The histamine content and the number of histamine-storing endocrine ('entero-chromaffin-like') cells in the oxyntic mucosa was almost doubled and the mucosal
histidine decarboxylase
activity was greatly elevated following antrum exclusion. 3. At the ultrastructural level both types of histamine-storing endocrine cells (ECL and A-like) were found to be enlarged and to have a reduced number of granules per unit cytoplasm. These changes are compatible with an increased secretory activity. The G (
gastrin
) cells were not increased in size but their granule volume density was lowered. 4. We propose that antrum exclusion results in uninhibited
gastrin
release causing profound changes in the histamine-storing endocrine cells of the oxyntic mucosa. The cells respond to the hypergastrinemia by an increase in functional activity (activation of
histidine decarboxylase
and reduction of granule volume density) as well as by an increase in number and size.
...
PMID:Effect of antrum exclusion on endocrine cells of rat stomach. 43 21
1.
Gastrin
activates rat stomach
histidine decarboxylase
. Exogenous histamine suppressed the basal enzyme activity in unoperated, in nephrectomized, in vagally denervated and in antrectomized rats, and counteracted the pentagastrin-induced enzyme activation in unoperated rats.2. Kinetic analysis of enzyme-catalysed histidine decarboxylation in extracts from untreated vagotomized and from histamine-treated vagotomized rats showed that the histamine-induced suppression of
histidine decarboxylase
activity probably reflects a reduced enzyme concentration. Moreover, the enzyme half-life in vagotomized rats after treatment with histamine was shorter than the half-life observed after inhibition of enzyme synthesis. These observations suggest that administration of histamine not only inhibits enzyme synthesis but also causes an accelerated rate of elimination of
histidine decarboxylase
.3. Intravenous infusion of histamine caused marked displacement of the pentagastrin dose-response curve, in a manner suggesting a reduced sensitivity to pentagastrin.4. After H(2)-receptor blockade, but not after H(1)-receptor blockade, histamine was less effective in suppressing the enzyme activity. Furthermore, H(2)-receptor blockade augmented the pentagastrin-induced enzyme activation.5. The results suggest that histamine (via H(2)-receptors) reduces the sensitivity of the histamine-storing cells to
gastrin
and that H(2)-receptor blockade induces the opposite effects.6. We propose that the histamine-storing cells in the rat stomach are endowed with H(2)-receptors and that exogenous histamine is capable of acting directly on the histamine cells. This may reflect a physiological control mechanism whereby mobilized endogenous histamine modifies its own synthesis and release.
...
PMID:Suppression of rat stomach histidine decarboxylase activity by histamine: H2-receptor-mediated feed-back. 89 8
1
2
3
4
5
6
7
8
9
10
Next >>